tiprankstipranks
Advertisement
Advertisement

RADX Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
9d ago
RADX
SMMT
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial
PremiumCompany Announcements
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial
9d ago
6K
RADX
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
PremiumRatings
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
10d ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
10d ago
RADX
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart
PremiumCompany Announcements
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart
1M ago
6K
RADX
Radiopharm doses first patient in Phase 1/2a study of BetaBart
PremiumThe FlyRadiopharm doses first patient in Phase 1/2a study of BetaBart
1M ago
RADX
Radiopharm reports cash balance of $34.52M as of December 31
Premium
The Fly
Radiopharm reports cash balance of $34.52M as of December 31
2M ago
RADX
Radiopharm Theranostics Lifts Stake in MD Anderson Joint Venture to 87.5% as Lead B7H3 Drug Enters Clinic
Premium
Company Announcements
Radiopharm Theranostics Lifts Stake in MD Anderson Joint Venture to 87.5% as Lead B7H3 Drug Enters Clinic
3M ago
6K
RADX
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
PremiumThe Fly
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
3M ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
AIM
RADX
Radiopharm price target raised to $15 from $12 at Maxim
PremiumThe Fly
Radiopharm price target raised to $15 from $12 at Maxim
4M ago
RADX
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
PremiumRatings
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
4M ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
RADX
Radiopharm price target raised to $16 from $13 at B. Riley
Premium
The Fly
Radiopharm price target raised to $16 from $13 at B. Riley
4M ago
RADX
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
4M ago
AMD
GOOG
Why Is Radiopharm Theranostics Stock (RADX) Up Today?
PremiumMarket News
Why Is Radiopharm Theranostics Stock (RADX) Up Today?
4M ago
RADX
Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial
PremiumThe Fly
Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial
4M ago
RADX
Radiopharm Theranostics Announces Successful General Meeting Resolutions
PremiumCompany Announcements
Radiopharm Theranostics Announces Successful General Meeting Resolutions
4M ago
6K
RADX
Radiopharm price target lowered to $13 from $15 at B. Riley
PremiumThe Fly
Radiopharm price target lowered to $13 from $15 at B. Riley
4M ago
RADX
Radiopharm receives approval to initiate Phase 1 trial of RAD 402
PremiumThe FlyRadiopharm receives approval to initiate Phase 1 trial of RAD 402
5M ago
RADX
Radiopharm announces 50% enrollment in Phase 2b trial of RAD101
Premium
The Fly
Radiopharm announces 50% enrollment in Phase 2b trial of RAD101
5M ago
RADX
Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204
Premium
The Fly
Radiopharm starts enrollment of third cohort in Phase 1 trial of 177Lu-RAD204
5M ago
RADX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >